Month: May 2025

Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on May 9, 2025. Posted in Earnings Releases And Operating Results.

Net Income of $3.7 million; reaffirms Full-Year Revenue Guidance of $118–$128 millionQ1 2025 revenue of $22.1 million; GAAP basic EPS: $0.03 Completed data collection and achieved database lock for the pivotal Phase 3 trial of Hydronidone in Chronic Hepatitis B (“CHB”)-associated liver fibrosis; currently reviewing data and on track to report topline results in Q2 2025 Received IND approval from China’s National Medical Products Administration (“NMPA”) for a new indication of pirfenidone to treat radiation-induced lung injury (“RILI”), with or without immune-related pneumonitis (“CIP”), marking Gyre’s first entry into oncology supportive care space Initiated commercialization of avatrombopag in China in March 2025, building a strategic presence with liver disease specialists Nintedanib remains on track for commercialization in May 2025,...

Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025

Written by Customer Service on May 9, 2025. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, presented results from the Phase 2b SYMMETRY trial demonstrating the potential of efruxifermin (EFX) to improve fibrosis in compensated cirrhosis (F4) caused by metabolic dysfunction-associated steatohepatitis (MASH), in a late-breaking oral presentation at the European Association for the Study of the Liver (EASL) Congress 2025 taking place May 7-10, in Amsterdam, the Netherlands. “Compensated cirrhosis due to MASH remains a high unmet medical need, leaving patients with a poor prognosis and currently no effective treatment options beyond liver transplant,” said Kitty Yale, chief development...

Gravity Reports First Quarter of 2025 Results and Business Update

Written by Customer Service on May 9, 2025. Posted in Public Companies.

Seoul, South Korea, May 09, 2025 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the first quarter ended March 31, 2025, prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and business updates. FIRST QUARTER 2025 HIGHLIGHTSTotal revenues were KRW 137,464 million (US$ 93,231 thousand), representing a 6% increase from the fourth quarter ended December 31, 2024 (“QoQ”) and a 14.8% increase from the first quarter ended March 31, 2024 (“YoY”).Operating profit was KRW 24,730 million (US$ 16,772 thousand), representing a 55% increase QoQ and an 8% decrease YoY.Profit before income tax expenses...

Nordic American Tankers Ltd (NYSE: NAT) – The company is in an active phase of development

Written by Customer Service on May 9, 2025. Posted in Public Companies.

Friday, May 9, 2025 Dear Shareholders and Investors, The first months of 2025 since the end of 2024 has been the most active period in Nordic American (NAT) for several years. The path forward is up. Dividend is a priority. As per previous communication to the market, we are in the process of acquiring two or three vessels and to sell a few ships. We have purchased two vessels, declared purchase options on two of our lease financed ships and subsequently refinanced them. As a part of our total plan, two of our early built vessels have been sold. Below is pertinent information, reflecting the active period since the start of 2025: January 22nd, 2025, NAT announced that it had declared the purchase option for the 2018 built Suezmax Nordic Aquarius. The purchase option price was $24 mill and a refinancing of the ship, reflecting...

Himax to Debut Breakthrough Ultra-Luminous Miniature Dual-Edge Front-lit LCoS Microdisplay at SID Display Week 2025

Written by Customer Service on May 9, 2025. Posted in Public Companies.

Setting the Standard for Next-Gen AR Applications and Optical Systems with Industry-Leading Brightness, Power Efficiency and an Ultra-Compact Form Factor TAINAN, Taiwan, May 09, 2025 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced the unveiling of its miniature ultra-luminous Dual-Edge Front-lit LCoS microdisplay at Display Week 2025. Organized by the Society for Information Display (SID), Display Week is one of the premier symposiums and exhibitions in the display industry and taking place May 11–16, 2025 in San Jose. Himax Senior Director, Simon Fan-Chiang will deliver an in-depth presentation on this cutting-edge technology during Session 3 of the symposium on May 13. Himax’s proprietary...

APMH Invest has obtained all necessary regulatory approvals for the all-cash recommended purchase offer for the shares in Svitzer

Written by Customer Service on May 9, 2025. Posted in Mergers And Acquisitions.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Reference is made to company announcements dated 2 April 2025 and 1 May 2025 concerning APMH Invest A/S’ (“APMHI”), a wholly owned subsidiary of A.P. Møller Holding A/S, all-cash voluntary recommended purchase offer to acquire all of the issued shares (the “Shares”) in Svitzer Group A/S (“Svitzer”), except for Shares owned by APMHI and Shares held by Svitzer and/or its subsidiaries in treasury, if any (the “Offer”). APMHI has today informed Svitzer that it has received the regulatory approval from the Secretary of State in the United Kingdom. Accordingly, APMHI has received all regulatory approvals required for completion of the Offer. Completion of the Offer remains subject to the satisfaction...

Solar A/S: No. 5 2025 Revenue returns to growth

Written by Customer Service on May 9, 2025. Posted in Earnings Releases And Operating Results.

Q1 revenue and EBITDA are in line with our expectations. We confirm our EBITDA guidance of between DKK 530m and DKK 600m for 2025. CEO Jens Andersen says:“All markets and main segments have rebounded, resulting in a positive organic growth of 6.5% – a significant improvement from the -15.4% in Q1 2024. This pick-up strengthened our underlying financial performance. We have initiated measures to optimise our operating model, including cost containment, process improvements and staff reductions. Consequently, costs in Q1 include restructuring costs of approx. DKK 40m, which will result in similar savings in the rest of 2025, and full-year savings of approx. DKK 60m going forward. As part of our investment in a new logistics centre in Kumla, we have chosen to fast-track the closing of our warehouse in Halmstad to optimise our...

MT Højgaard Holding A/S: Good start to 2025

Written by Customer Service on May 9, 2025. Posted in Earnings Releases And Operating Results.

FIRST-QUARTER RESULTS In the first quarter, MT Højgaard Holding consolidated its positive developments, reduced the loss from the winding up of the international activities and ensured progress for its strategic focus areas.Revenue increased by 14% to DKK 2,625 million, driven by a higher level of activity and faster progress on several projects. MT Højgaard Danmark and Enemærke & Petersen both recorded double-digit growth, which was particularly strong in the focus areas of civil engineering and infrastructure as well as partnership projects. Operating profit (EBIT) rose by 5% to DKK 99 million. MT Højgaard Danmark increased its earnings on the back of high efficiency, good capacity utilisation and revaluation of individual projects. On the other hand, earnings in Enemærke & Petersen fell as expected. The continuing operations...

AKVA group ASA: Q1 2025 financial reporting

Written by Customer Service on May 9, 2025. Posted in Earnings Releases And Operating Results.

High activity level and improved profitability AKVA group delivered high quarterly revenue in Q1 2025 of MNOK 1 013 (784), an increase of 29% compared to Q1 2024. EBITDA increased from MNOK 67 in Q1 2024 to MNOK 113 in Q1 2025. Total order intake of BNOK 1,2 in Q1 2025, up from MNOK 917 in Q1 2024. Order backlog was BNOK 2,8 at the end of March 2025. RAS contract from Cermaq Chile regarding smolt facility signed in February 2025 with contract value of approx. MEUR30. Sale of shares in Abyss Group to Arcus Infrastructure Partners with net proceeds of approx. MNOK 144 and net gain of MNOK 12 The activity level in the first quarter of 2025 was high with revenue of MNOK 1 013 and order intake of MNOK 1 200. The high order intake in the quarter was supported by the award of the smolt contract from Cermaq Chile and continued strong momentum...

Brunel Q1 2025 results: Operating in challenging market conditions

Written by Customer Service on May 9, 2025. Posted in Earnings Releases And Operating Results.

Amsterdam, 9 May 2025 – Brunel International N.V. (Brunel; BRNL), a global specialist delivering customised project and workforce solutions to drive sustainable industry transformations through technology and talent, today announced its results for the first quarter 2025. Q1 2025 HighlightsTotal Revenue of EUR 310.5 million, down 11% (down 10% organically) Gross Profit of EUR 56.5 million, down 18% (down 17% organically) Cost reduction program delivered EUR 6 million lower cost to EUR 48.1m, down 11% Underlying EBIT of EUR 8.4 million, down 44% (down 35% organically)Peter de Laat, CEO: “As expected, we faced a challenging first quarter in 2025. The combination of increasing geopolitical uncertainty and a weakening economic environment caused further delays in new projects being started by our clients. This particularly impacted...

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals